These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15479447)

  • 21. Regulated motion of glycoproteins revealed by direct visualization of a single cargo in the endoplasmic reticulum.
    Nagaya H; Tamura T; Higa-Nishiyama A; Ohashi K; Takeuchi M; Hashimoto H; Hatsuzawa K; Kinjo M; Okada T; Wada I
    J Cell Biol; 2008 Jan; 180(1):129-43. PubMed ID: 18195104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant quality control in the endoplasmic reticulum impairs the biosynthesis of pulmonary surfactant in mice expressing mutant BiP.
    Mimura N; Hamada H; Kashio M; Jin H; Toyama Y; Kimura K; Iida M; Goto S; Saisho H; Toshimori K; Koseki H; Aoe T
    Cell Death Differ; 2007 Aug; 14(8):1475-85. PubMed ID: 17464327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning and characterization of two soybean protein disulfide isomerases as molecular chaperones for seed storage proteins.
    Kamauchi S; Wadahama H; Iwasaki K; Nakamoto Y; Nishizawa K; Ishimoto M; Kawada T; Urade R
    FEBS J; 2008 May; 275(10):2644-58. PubMed ID: 18422652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological chaperone action on G-protein-coupled receptors.
    Bernier V; Bichet DG; Bouvier M
    Curr Opin Pharmacol; 2004 Oct; 4(5):528-33. PubMed ID: 15351360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo analysis of the lumenal binding protein (BiP) reveals multiple functions of its ATPase domain.
    Snowden CJ; Leborgne-Castel N; Wootton LJ; Hadlington JL; Denecke J
    Plant J; 2007 Dec; 52(6):987-1000. PubMed ID: 17971046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is all of the endoplasmic reticulum created equal? The effects of the heterogeneous distribution of endoplasmic reticulum Ca2+-handling proteins.
    Papp S; Dziak E; Michalak M; Opas M
    J Cell Biol; 2003 Feb; 160(4):475-9. PubMed ID: 12591911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug development and the cellular quality control system.
    Conn PM; Janovick JA
    Trends Pharmacol Sci; 2009 May; 30(5):228-33. PubMed ID: 19307028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular chaperones and protein quality control.
    Bukau B; Weissman J; Horwich A
    Cell; 2006 May; 125(3):443-51. PubMed ID: 16678092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation.
    Petäjä-Repo UE; Hogue M; Bhalla S; Laperrière A; Morello JP; Bouvier M
    EMBO J; 2002 Apr; 21(7):1628-37. PubMed ID: 11927547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein folding and modification in the mammalian endoplasmic reticulum.
    Braakman I; Bulleid NJ
    Annu Rev Biochem; 2011; 80():71-99. PubMed ID: 21495850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The action of molecular chaperones in the early secretory pathway.
    Fewell SW; Travers KJ; Weissman JS; Brodsky JL
    Annu Rev Genet; 2001; 35():149-91. PubMed ID: 11700281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-linked carbohydrates act as lumenal maturation and quality control protein tags.
    Daniels R; Svedine S; Hebert DN
    Cell Biochem Biophys; 2004; 41(1):113-38. PubMed ID: 15371643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum.
    Michalak M; Groenendyk J; Szabo E; Gold LI; Opas M
    Biochem J; 2009 Feb; 417(3):651-66. PubMed ID: 19133842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
    Apodaca J; Kim I; Rao H
    Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ER and aging-Protein folding and the ER stress response.
    Naidoo N
    Ageing Res Rev; 2009 Jul; 8(3):150-9. PubMed ID: 19491040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for mutants defective in secretory protein maturation and ER quality control.
    Ng DT
    Methods; 2005 Apr; 35(4):366-72. PubMed ID: 15804609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folding of secretory and membrane proteins.
    Kuznetsov G; Nigam SK
    N Engl J Med; 1998 Dec; 339(23):1688-95. PubMed ID: 9834307
    [No Abstract]   [Full Text] [Related]  

  • 39. The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules.
    Cabrera CM
    Scand J Immunol; 2007 Jun; 65(6):487-93. PubMed ID: 17523940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FKBP22 is part of chaperone/folding catalyst complexes in the endoplasmic reticulum of Neurospora crassa.
    Tremmel D; Duarte M; Videira A; Tropschug M
    FEBS Lett; 2007 May; 581(10):2036-40. PubMed ID: 17470367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.